Individual Paper Summaries

1. E. Levy - Functional Constipation in Children: Challenges and Solutions (2017)

• FC is one of the most common GI complaints in children, accounting for 3-5% of pediatric outpatient visits and up to 25% of pediatric gastroenterology referrals.
• The Rome IV criteria (2016) define FC by at least 2 of the following (for ≥1 month in infants/toddlers; ≥2 months in older children): ≤2 defecations/week, fecal incontinence, retentive posturing, painful/hard stools, large fecal mass in the rectum, large-diameter stools.
• Pathophysiology involves a vicious cycle: painful defecation leads to voluntary stool withholding, progressive rectal distension, reduced rectal sensitivity, and worsening constipation.
• Treatment approach: Disimpaction first (oral polyethylene glycol [PEG] preferred over rectal enemas in most cases), followed by maintenance laxative therapy (PEG as first-line), dietary adjustments (adequate fiber and fluid intake), and behavioral/toilet training.
• Challenges include poor medication adherence, parental reluctance to use laxatives long-term, recurrence, and the need to distinguish FC from organic causes (Hirschsprung disease, hypothyroidism, celiac disease).
• Long-term follow-up is essential - roughly 50% of children still need laxatives after 5 years.

2. WJG-22-567 - World Journal of Gastroenterology (Volume 22, Article 567)

3. L. Lladó - Techniques of Orthotopic Liver Transplantation (2004)

• Orthotopic liver transplantation (OLT) replaces the native liver in its anatomical position and remains the definitive treatment for end-stage liver disease, acute liver failure, and select hepatic malignancies.
• Donor hepatectomy and graft preparation: Describes back-table preparation, flushing with preservation solutions (University of Wisconsin [UW] solution or HTK), and arterial/venous reconstruction.
• Recipient hepatectomy: Two main techniques - classical (with infrahepatic/suprahepatic IVC clamping) vs. the piggyback technique (preservation of the recipient IVC by side-clamping, reducing hemodynamic instability).
• Hepatic artery reconstruction - standard end-to-end anastomosis; alternatives when donor/recipient anatomy is anomalous.
• Venous outflow and portal reconstruction - end-to-end portal vein anastomosis.
• Biliary reconstruction - end-to-end choledochocholedochostomy (preferred) vs. Roux-en-Y hepaticojejunostomy when biliary anatomy precludes direct anastomosis.
• Venovenous bypass (now less commonly used) can reduce hemodynamic changes during the anhepatic phase.

4. Preventing Muscle Loss (2019-era, likely from a clinical nutrition or exercise science journal)

• Sarcopenia (loss of skeletal muscle mass and function) is associated with aging, prolonged immobility, malnutrition, and post-surgical states.
• Protein intake: Adequate dietary protein (≥1.2 g/kg/day in older adults; higher in critically ill patients) is the most evidence-backed nutritional strategy.
• Resistance exercise is the gold-standard intervention for maintaining and building muscle.
• Leucine and essential amino acids (EAAs) - especially leucine - stimulate muscle protein synthesis via the mTOR pathway.
• Hormonal factors (testosterone, IGF-1, vitamin D deficiency) play modulatory roles.
• Pharmacological interventions (e.g., anabolic steroids, SARMs, myostatin inhibitors) are investigational.

5. R. Poon - Hepatectomy for Hepatocellular Carcinoma: Patient Selection and Postoperative Outcome (2004)

• Hepatic resection is the preferred curative option for HCC in non-cirrhotic livers and in selected cirrhotic patients with preserved hepatic function.
• Patient selection criteria: Adequate future liver remnant (FLR) volume (>20-25% in normal livers; >40% in cirrhotic livers), Child-Pugh A status, absence of portal hypertension (hepatic venous pressure gradient <10 mmHg), and acceptable tumor characteristics (solitary tumor, no macrovascular invasion).
• Portal vein embolization (PVE) can be used to induce hypertrophy of the FLR preoperatively.
• Major determinants of postoperative morbidity/mortality: underlying cirrhosis, extent of resection, blood loss, and need for transfusion.
• Cirrhotic patients have higher rates of post-hepatectomy liver failure (PHLF) - the leading cause of postoperative death.
• Outcomes: 5-year survival rates of 30-50% after curative resection; major determinants of recurrence include microvascular invasion, tumor size, and AFP levels.

6. s00423-020-01960-6 - Langenbeck's Archives of Surgery (2020)

7. R. Poon - Current Techniques of Liver Transection (2007)

• Liver transection (parenchymal division) is the most technically demanding and blood-loss-prone step of hepatectomy.
• Techniques reviewed:
  • Clamp-crushing (Kelly clamp): Traditional standard; surgeon crushes liver parenchyma to expose vessels for clipping/ligating. Widely available and effective.
  • CUSA (Cavitational Ultrasonic Surgical Aspirator): Uses ultrasonic vibration to selectively destroy hepatocytes while preserving vessels and bile ducts. Reduces blood loss vs. clamp-crushing in some studies.
  • Harmonic scalpel / ultrasonic dissector: Cuts and coagulates simultaneously, useful for smaller vessels.
  • Water-jet dissection: High-pressure water stream disrupts hepatocytes while preserving fibrovascular structures.
  • Radiofrequency-assisted transection (TissueLink/Habib): Coagulates a plane before cutting, reducing blood loss.
  • Stapling devices: Linear staplers for major vessels and large pedicles.
• Pringle maneuver (portal triad clamping) remains widely used to control intraoperative bleeding; intermittent clamping is better tolerated than continuous.
• No single technique has proven definitively superior in randomized trials; selection depends on surgeon experience and available equipment.

8. B. Regmi - An Overview of Current Status, Recent Techniques and Challenges of Liver Transplantation (2018)

• Indications: End-stage liver disease (cirrhosis from any cause), acute liver failure, HCC within Milan criteria, metabolic liver diseases (Wilson's, alpha-1 antitrypsin deficiency, etc.).
• Donor sources: Deceased donor (DDLT) - brain-dead and donation after cardiac death (DCD); living donor (LDLT) - right or left lobe.
• Organ shortage: The major challenge globally; LDLT has expanded the donor pool especially in Asia where DDLT rates are low.
• Allocation: MELD (Model for End-stage Liver Disease) score-based allocation in the US/Europe.
• Immunosuppression: Calcineurin inhibitors (tacrolimus preferred over cyclosporine) as backbone; combined with mycophenolate mofetil and/or corticosteroids.
• Outcomes: 1-year survival >90% at experienced centers; 5-year survival ~75%.
• Challenges: Primary non-function, biliary complications (anastomotic/non-anastomotic strictures, biliary leaks), hepatic artery thrombosis, acute and chronic rejection, de novo malignancies from long-term immunosuppression, and recurrence of underlying disease (particularly HCV - now largely curable with DAAs, and HBV).
• Recent advances: Machine perfusion (normothermic and hypothermic) to assess and recondition marginal grafts; expanded criteria donors; ABO-incompatible LDLT.

9. G. Rubin - Chronic Constipation in Children (2006)

• Constipation affects 5-10% of children; in most cases it is functional (no organic cause).
• Rome II/III diagnostic criteria used at the time: infrequent stools, hard/painful passage, fecal soiling, withholding behavior.
• Red flags suggesting organic cause: Onset <1 month of age, failure to pass meconium within 48 hours (Hirschsprung disease), ribbon stools, distended abdomen, neurological abnormalities, sacral dimple/hair tuft, poor growth.
• Assessment: Mainly clinical - digital rectal exam can confirm impaction; plain abdominal X-ray not routinely recommended but can confirm fecal loading; anorectal manometry/biopsy if Hirschsprung disease suspected.
• Management:
  1. Disimpaction: Oral laxatives (Movicol/PEG) or enemas
  2. Maintenance: Lactulose or Movicol long-term; avoid dietary bran in young children
  3. Behavioral: Regular toilet sitting after meals (exploiting gastrocolic reflex), positive reinforcement, reward charts
  4. Diet: Adequate fluids and fruit; evidence for high fiber in children is weak
• Majority of children respond to laxative treatment but long-term follow-up (at least 6-12 months of maintenance) is required to prevent relapse.

• WJG-22-567 - The World Journal of Gastroenterology reference is ambiguous without the full title or authors. Hundreds of articles carry this journal code.
• s00423-020-01960-6 - This Langenbeck's Archives of Surgery (2020) paper could be one of many articles published that year.